Skip to content
HowShorted

GENOCEA BIOSCIENCES, INC. short interest in 2019

In 2019, GENOCEA BIOSCIENCES, INC.'s disclosed short interest ran from 2.24% of shares outstanding on 15 Jan 2019 to 0.37% on 31 Dec 2019, a change of -1.87 percentage points. The year's high was 2.24% on 15 Jan 2019 and its low 0.31% on 13 Dec 2019, averaging 1.17% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 19.40 days on 31 Jan 2019. Full history: GENOCEA BIOSCIENCES, INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for GENOCEA BIOSCIENCES, INC. in 2019

2019 in figures

Start of year
2.24% (15 Jan 2019)
End of year
0.37% (31 Dec 2019)
Change
-1.87 pp
High
2.24% (15 Jan 2019)
Low
0.31% (13 Dec 2019)
Average
1.17%
Highest days to cover
19.40 (31 Jan 2019)
SEC filings marked
8

Every report in 2019

GENOCEA BIOSCIENCES, INC. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 20192.24%4.40
31 Jan 20192.18%19.40
15 Feb 20192.14%9.53
28 Feb 20191.83%1.2110-K filed, results (8-K)
15 Mar 20191.56%4.01
29 Mar 20191.52%5.45
15 Apr 20191.47%2.01
30 Apr 20191.22%4.6210-Q filed, results (8-K)
15 May 20191.27%4.93
31 Jul 20191.92%2.3910-Q filed, results (8-K)
15 Aug 20191.17%2.47
30 Aug 20190.99%3.18
13 Sep 20190.74%1.00
30 Sep 20190.68%1.47
15 Oct 20190.50%1.62
31 Oct 20190.49%1.2710-Q filed, results (8-K)
15 Nov 20190.40%1.00
29 Nov 20190.41%1.00
13 Dec 20190.31%1.00
31 Dec 20190.37%1.00

See also: GENOCEA BIOSCIENCES, INC.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.